Cardiorenal-Metabolic Summit – Ghana 2026

The Cardiorenal-Metabolic Summit – Ghana 2026 is a half-day, faculty-led scientific meeting for physicians, specialists and allied prescribers managing patients with type 2 diabetes, hypertension, chronic kidney disease and heart failure. It is built on a single premise: these are not four separate diseases in four separate clinics, but overlapping manifestations of one cardiovascular-kidney-metabolic continuum in one patient.

Across four scientific sessions and an integrated grand-round panel, faculty will move the conversation beyond glycaemic control alone towards organ protection. Sessions cover repositioning cardiorenal protection as a treatment priority in type 2 diabetes; practical strategies for detecting chronic kidney disease early in hypertensive and diabetic populations; accelerating foundational guideline-directed medical therapy across the heart failure ejection-fraction spectrum; and confronting the residual cardiovascular risk that persists after conventional lipid targets are met.

The programme is deliberately practice-oriented. Each session is anchored in current international guidance and interpreted for the Ghanaian clinical setting, with attention to what can realistically be screened, initiated and monitored at district, regional and teaching hospital level. The closing grand-round panel takes a single integrated patient scenario and work through the treatment decisions collectively, so that participants leave with a defined set of take-home actions rather than four parallel sets of recommendations

Facilitated by distinguished clinicians and subject matter experts with extensive experience in cardiovascular, renal, metabolic and diabetes care, this highly interactive session combines expert presentations, real-world clinical perspectives, and a dynamic expert panel discussion that will allow participants to engage directly with leading specialists.

Whether you are involved in primary care, specialist practice, hospital medicine, pharmacy, nursing, or any discipline involved in the care of patients with diabetes, kidney disease, or cardiovascular conditions, this event promises practical knowledge that can immediately enhance clinical practice.

WHY YOU SHOULD ATTEND

This programme has been carefully designed to deliver practical, evidence-based knowledge that can be applied immediately in clinical practice.

By attending, you will:  

1.       Explain the cardiovascular-kidney-metabolic continuum and justify why a single patient with type 2 diabetes, hypertension,   CKD or heart failure requires integrated rather than organ-siloed management.

2.       Reposition cardiorenal protection as a treatment priority in type 2 diabetes, selecting therapy on the basis of comorbidity and   organ risk rather than HbA1c alone.

3.       Apply a practical CKD screening algorithm in hypertensive and diabetic patients using eGFR and urine albumin-to-creatinine   ratio, and interpret results against the KDIGO risk classification.

4.     Initiate and up-titrate foundational guideline-directed medical therapy across the heart failure ejection-fraction spectrum, and identify the causes of clinical inertia that delay complete therapy.

5.  Define residual cardiovascular risk, apply guideline LDL-C goals for high and very-high-risk patients, and escalate lipid-lowering therapy appropriately when goals are not met.

6.  Translate the above into a coordinated management plan for a patient presenting with more than one cardiorenal-metabolic condition.

     7. Participate in a highly interactive learning experience with opportunities to ask questions and discuss real-world clinical challenges

      8. Earn accredited CPD points from the relevant professional regulatory bodies.

      9. Network virtually with colleagues and experts across multiple healthcare disciplines.

TOPICS TO BE PRESENTED

The programme will include presentations on:

 i. Beyond HbA1c: Repositioning Cardiorenal Protection as a Treatment Priority in Type 2 Diabetes

 ii. Detecting Chronic Kidney Disease Early: Screening and Intervention Strategies in Hypertension and Type 2 Diabetes.

 iii. Across the Heart Failure Spectrum: Accelerating Foundational GDMT in HFrEF and HFpEF.

 iv. Dyslipidaemia in CVRM Disease: Confronting the Residual Risk We Cannot Ignore.

 v. One patient, multiple organs: why integrated CVRM care matters.

 vi. Expert Panel Discussion and Interactive Question & Answer Session

EVENT HIGHLIGHTS

Participants can look forward to:

1. Expert-led presentations by highly experienced clinicians

 2. Latest evidence-based updates in CRM management 

 3. Practical clinical guidance applicable to everyday practice 

 4. Interactive discussions with opportunities to ask questions

 5. Expert Panel Discussion featuring experienced specialists

 6. Real-world clinical insights and case-based learning

 7. Accredited CPD points upon successful participation

 9. Fully hybrid participation from any location

PROUDLY SPONSORED BY

This is a hybrid event. The CPD event will be streamed LIVE on this page.

Scientific Chair / Moderator: Prof. Vincent Boima

Date:  Thurs. 27th August, 2026

Time: 1600 GMT (4:00pm local time)

Target Audience: Medical Doctors & Pharmacists

In-person attendance at the Alisa Hotel, Accra.

Don’t miss out on this exciting opportunity to elevate your skills and make a lasting impact!

PARTICIPANT CONSENT AND DATA PRIVACY NOTICE

By registering for "Cardiorenal-Metabolic Summit – Ghana 2026", you consent to participate in this training hosted by Continuous Education Services (CES) on behalf of Astrazeneca.

Your registration information will be used solely to facilitate your participation in the training and to process Continuing Professional Development (CPD) accreditation with the Medical and Dental Council (MDC) and the Pharmacy Council, where applicable.

CES is committed to protecting your privacy and maintaining the confidentiality of your personal information. Your personal data will not be shared with Astrazeneca. Information collected during registration will only be disclosed to the relevant professional regulatory authorities for the exclusive purpose of awarding CPD points earned through participation in this programme.

Participation in this event is entirely voluntary. You are free to leave the hybrid meeting at any time without any further obligation. CES remains committed to handling all participant information securely, responsibly, and in accordance with applicable data protection and privacy principles.